Gabrielle Emanuel

Shanna LaFountain has been a nursing assistant in New England for 20 years. About two months ago, in the middle of the coronavirus pandemic, she stopped working.

"It was an extremely hard decision," she said.

LaFountain has three children and made the decision once their schools closed and their learning went online.

"My son was not answering teachers, not doing assignments," she said. "I had to be home with my children."

Sentencing is scheduled to begin on Monday in the criminal trial of top executives at Insys Therapeutics. This landmark case was the first successful prosecution of high-ranking pharmaceutical executives linked to the opioid crisis, including onetime billionaire John Kapoor.

Insys Therapeutics, an opioid manufacturer, has agreed to pay $225 million to settle the federal government's criminal and civil investigations into the company's marketing practices. As part of the settlement, Insys Therapeutics admitted to bribing doctors to prescribe its opioid painkiller.

Last month, a federal jury in Boston found five top Insys Therapeutics executives guilty of racketeering conspiracy for these same practices. Now, the federal government is holding the company accountable.

Steven Senne / AP

The University at Buffalo Council has passed a resolution to “un-name” the pharmacy school building named in honor of John Kapoor. Kapoor was convicted of racketeering conspiracy by a federal jury last month.

Copyright 2019 WGBH Radio. To see more, visit WGBH Radio.

AILSA CHANG, HOST:

Updated 5:30 p.m. ET

A jury in Boston has found onetime billionaire and drug company executive John Kapoor and his four co-defendants guilty of a racketeering conspiracy. The verdict came Wednesday after 15 days of deliberation.